Results 81 to 90 of about 4,513 (219)

Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. [PDF]

open access: yes, 2014
BACKGROUND In the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) factorial trial, the combination of perindopril and indapamide reduced mortality among patients with type 2 diabetes, but ...
Arima, H   +29 more
core   +4 more sources

EFFECT OF COMBINATION THERAPY WITHFOSINOPRIL AND MELDONIUM ON THE INDICES OF 48-HOUR MONITORING OF BLOOD PRESSURE AND MYOCARDIUM GEOMETRY IN HEMODIALYSIS PATIENTS WITH CHRONIC HEART FAILURE

open access: yesУкраїнський Журнал Нефрології та Діалізу, 2017
Despite medical advances, cardiovascular complications continue to dominate in patients treated with hemodialysis. Therefore, the search for new methods of diagnosis and treatment is advisable.
T.I. Salyzhyn
doaj   +1 more source

The Medicare Part D Coverage Gap: Costs and Consequences in 2007 [PDF]

open access: yes, 2008
Analyzes data on Medicare Part D enrollees who reached the coverage gap and had to pay the full cost until they qualified for catastrophic coverage, who then stopped taking their medications or bought cheaper ones, and who received catastrophic ...
Elizabeth Hargrave   +3 more
core  

The lack of the Celf2a splicing factor converts a Duchenne genotype into a Becker phenotype [PDF]

open access: yes, 2016
Substitutions, deletions and duplications in the dystrophin gene lead to either the severe Duchenne muscular dystrophy (DMD) or mild Becker muscular dystrophy depending on whether out-of-frame or in-frame transcripts are produced.
BOZZONI, Irene   +7 more
core   +2 more sources

Fosinopril – a drug of choice in chronic heart failure prevention and treatment

open access: yesКардиоваскулярная терапия и профилактика, 2006
Aim. To study ACE inhibitor fosinopril effects on remodeling, diastolic filling of left and right ventricles (LV, RV), ectopic myocardial activity, heart rate variability, endothelial function, and microcirculation in patients with arterial hypertension (
N. Yu. Khosyainova   +3 more
doaj  

THE PLACE OF FOSINOPRIL IN EVIDENCE-BASED TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION

open access: yesМедицинский совет, 2017
Cardiovascular diseases (CVD) remain the main cause of mortality in the world. [1] At the same time, arterial hypertension (AH) is one of the most common CV pathologies, which, according to foreign researchers, affects about 30–45% of the general ...
S. A. Berns, R. I. Stryuk
doaj   +1 more source

EVALUASI KETEPATAN PEMILIHAN OBAT PADA PASIEN HIPERTENSI DI INSTALASI RAWAT INAP RUMAH SAKIT UMUM DAERAH DR. MOEWARDI SURAKARTA PERIODE JANUARI–JULI TAHUN 2009 [PDF]

open access: yes, 2010
Hipertensi merupakan penyakit yang berkaitan dengan penurunan usia harapan hidup dan peningkatan risiko stroke, penyakit jantung koroner, dan penyakit organ target lainnya.
QASHDINA, HAZHIYAH
core  

CURRENT PROSPECTS FOR THE TREATMENT OF DIABETES COMPLICATIONS

open access: yesМедицинский совет, 2016
Arterial hypertension (AH) complicates the course of diabetes mellitus (DM) of both the 1st and 2nd type. In patients with diabetes type 1, the main cause of AH is diabetic nephropathy.
M. Y. OGARKOV, Y. V. KOVALEVA
doaj   +1 more source

Survival prospects after acute myocardial infarction in the UK: a matched cohort study 1987–2011 [PDF]

open access: yes, 2017
Objectives: Estimate survival after acute myocardial infarction (AMI) in the general population aged 60 and over, and the effect of recommended treatments.
Gitsels, Lisanne A   +2 more
core   +1 more source

Selection of an ACE inhibitor in clinical practice

open access: yesМедицинский совет, 2014
Currently, ACE inhibitors are considered to be the gold standard in the treatment of cardiovascular diseases. They all have cardio-, vaso- and nephroprotective and positive metabolic effects; however, despite the large number of the so-called class ...
OD Ostroumova   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy